Leukotriene modifier therapy for mild sleep-disordered breathing in children

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 3, 2005, Pages 364-370

  Goldbart, Aviv D ^b   Goldman, Julie L ^b   Veling, Maria C ^b   Gozal, David ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Adenotonsillectomy; Leukotriene receptors; Lymphoid hyperplasia; Sleep apnea; Tonsils

Indexed keywords

LEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE 2 RECEPTOR; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; MONTELUKAST; UNCLASSIFIED DRUG;

ADENOID; ADENOTONSILLECTOMY; ARTICLE; CERVICAL SPINE RADIOGRAPHY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PHARYNGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; TONSIL; WESTERN BLOTTING;

ACETATES; ADMINISTRATION, ORAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; POLYSOMNOGRAPHY; QUINOLINES; RECEPTORS, LEUKOTRIENE; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 22244471654     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200408-1064OC     Document Type: Article

References (47)

1. Kaditis AG, Finder J, Alexopoulos EI, Starantzis K, Tanou K, Gampeta S, Agorogiannis E, Christodoulou S, Pantazidou A, Gourgoulianis K, et al. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol 2004;37:499-509.
2. Arens R, McDonough JM, Corbin AM, Rubin NK, Carroll ME, Pack AI, Liu J, Udupa JK. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2003;167:65-70.
3. Rosen CL. Racial differences in the diagnosis of childhood obstructive sleep apnea (OSA). Am J Respir Crit Care Med 1998;157:A535.
4. Frank Y, Kravath RE, Pollak CP, Weitzman ED. Obstructive sleep apnea and its therapy: clinical and polysomnographic manifestations. Pediatrics 1983;71:737-742.
5. Tal A, Leiberman A, Margulis G, Sofer S. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol 1988;4:139-143.
6. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr 1982;100:31-40.
7. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998;157:1098-1103.
8. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102:616-620.
9. Guilleminault C, Winkle R, Korobkin R, Simmons B. Children and nocturnal snoring-evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr 1982;139:165-171.
10. Owens J, Opipari L, Mobile C, Spirito A. Sleep and daytime behavioral sleep disorders. Pediatrics 1998;102:1178-1184.
11. O'Brien LM, Gozal D. Behavioral and neurocognitive implications of snoring and obstructive sleep apnea in children: facts and theory. Paediatr Respir Rev 2002;3:3-9.
12. Schechter MS. Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:e69.
13. O'Brien LM, Mervis CB, Holbrook CR, Bruner JL, Klaus CJ, Rutherford J, Raffield TJ, Gozal D. Neurobehavioral implications of habitual snoring in children. Pediatrics 2004;114:44-49.
14. Brouillette RT, Manoukian JJ, Ducharme FM, Oudjhane K, Earle LG, Ladan S, Morielli A. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838-844.
15. Marcus CL. Nasal steroids as treatment for obstructive sleep apnea: don't throw away the scalpel yet. J Pediatr 2001;138:795-797.
16. Rubinstein I. Nasal inflammation is present in patients with obstructive sleep apnea. Laryngoscope 1995;105:175-177.
17. Sekosan M, Zakkar M, Wenig B, Olopade CO, Rubinstein I. Inflammation in the uvula mucosa with obstructive sleep apnea. Laryngoscope 1996;106:1018-1020.
18. Olopade CO, Christon JA, Zakkar M, Hua C, Swedler WI, Scheff PA, Rubinstein I. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997;111:1500-1504.
19. Boyd JH, Petrof BJ, Hamid Q, Fraser R, Kimoff RJ. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:541-546.
20. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004;113:564-569.
21. Singulair. Manufacturer's prescribing information. Whitehouse Station, NJ: Merck & Co, Inc.; 1999.
22. Becker A. Clinical evidence with montelukast in the management of chronic childhood asthma. Drugs 2000;59(Suppl 1):29-34.
23. Storms W, Michele TM, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, Reiss TF. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. Clin Exp Allergy 2001;31:77-87.
24. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2-5 years. Pediatrics 2001;108:e48.
25. Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, Becker A. Montelukast for chronic asthma in 6-14 year old children: a randomized double blind trial. JAMA 1998;279:1181-1186.
26. Villaran C, O'Neill SJ, Helbling A, van Noord JA, Lee TH, Chuchalin AG, Langley SJ, Gunawardena KA, Suskovic S, Laurenzi M, et al. Montelukast versus salmeterol in patients with asthma and exercise induces bronchoconstriction. J Allergy Clin Immunol 1999;104:547-553.
27. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789-793.
28. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000;275: 30531-30536.
29. Goldbart AD, Goldman GL, Li RC, Brittian KR, Tauman R, Gozal D. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea and recurrent infection. Chest 2004;126:13-18.
30. Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio. AJR Am J Roentgenol 1979;133:401-404.
31. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring systems for sleep stages of human subject. Washington DC: National Institutes of Health; 1968. Publication No. 204.
32. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996;153: 866-878.
33. Marcus CL, Omlin KJ, Basinki DJ, Bailey SL, Rachal AB, Von Pechmann WS, Keens TG, Ward SL. Normal polysomnographic values for children and adolescents. Am Rev Respir Dis 1992;156:1235-1239.
34. Sleep Disorders Atlas Task Force. EEG arousals: scoring and rules and examples. Sleep 1992;15:173-184.
35. Tauman R, O'Brien LM, Holbrook CR, Gozal D. Sleep pressure score: a new index of sleep disruption in snoring children. Sleep 2004;27:274-278.
36. O'Brien LM, Tauman R, Gozal D. Sleep pressure correlates of cognitive and behavioral morbidity in snoring children. Sleep 2004;27:279-282.
37. Montgomery-Downs HE, O'Brien LM, Holbrook CR, Gozal D. Snoring and sleep-disordered breathing in young children: subjective and objective correlates. Sleep 2004;27:87-94.
38. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.
39. Goodwin JL, Kaemingk KL, Fregosi RF, Rosen GM, Morgan WJ, Sherrill DL, Quan SF. Clinical outcomes associated with sleep-disordered breathing in Caucasian and Hispanic children-the Tucson Children's Assessment of Sleep Apnea study (TuCASA). Sleep 2003;26:587-591.
40. Al-Ghamdi SA, Manoukian JJ, Morielli A, Oudjhane K, Ducharme FM, Brouillette RT. Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? Laryngoscope 1997;107:1382-1387.
41. Goldbart AD, Veling MC, Goldman JL, Li RC, Brittian KR, Gozal D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea. Pediatr Res 2004;57:232-236.
42. Brooks LJ, Stephens BM, Bacevice AM. Adenoid size is related to severity but not the number of episodes of obstructive apnea in children. J Pediatr 1998;132:682-686.
43. Ebenfelt A, Ivarsson M. Neutrophil migration in tonsils. J Anat 2001; 198:497-500.
44. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464.
45. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, Zambito AM, Tracy RP, Jenny NS, Redline S. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005;111:1978-1984.
46. Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Germenis A, Zintzaras E, Gourgoulianis K. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005;171:282-286.
47. Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signaling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 2003;33:1380-1388.